Skip to Content

  • Search

View Additional Section Content

A randomized, double-blind, placebo-controlled, event-driven trial of weekly low-dose methotrexate (LDM) in the prevention of cardiovascular events among stable coronary artery disease patients with type 2 diabetes or metabolic syndrome

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT01594333?term=nct01594333&rank=1

Principal Investigator(s)
Vamshi K. Mallavarapu, M.D. (Sub-Investigator)
Adam M. Cohen, M.D.

Clinical Trial Categories

  • Cardiology
  • Diabetes
Contact
Matthew G. Dreese, MS at 215-481-4193

Location

  • Abington Medical Specialists

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details